Enanta"s HCV Collaboration Partner AbbVie receives Approval by the European Commission for MAVIRET (glecaprevir/pibrentasvir) to Shorten Treatment Duration to Eight...
WATERTOWN, Mass.--(BUSINESS WIRE)--Aug 2, 2019--
WATERTOWN, Mass.--(BUSINESS WIRE)--Aug 2, 2019--